CIT can broadcast your seminar, conference or meeting live to a world-wide
audience over the Internet as a real-time streaming video. The event can
be recorded and made available for viewers to watch at their convenience
as an on-demand video or a downloadable podcast. CIT can also broadcast
NIH-only or HHS-only content.
The Geroscience Interest Group (GSIG) cordially invites you to the seminar presented by Dr. Richard Miller. Dr. Miller is a Professor of Pathology and Director of the Nathan Shock Center on Aging at the University of Michigan. He directs one of the three laboratories involved in the NIA-sponsored Interventions Testing Program (ITP) and in that capacity made a seminal contribution to the discovery that rapamycin increases lifespan in mice. His seminar will provide further research information on the ITP, rapamycin and other anti-aging interventions. He has a wide interest in biogerontology, with a special emphasis on the use of animal models to study mechanisms regulating longevity and stress resistance.
The Geroscience Interest Group (GSIG) is a newly formed trans-NIH group aimed at enhancing opportunities for discussion of the intersection between the biology of aging and the biology of diseases and conditions that are of interest across ICs. It is focused on basic biology, but with a longer view towards translation.
Anti-aging medicines : the beginning of the end of the beginning [electronic resource] / Richard Miller ; Geroscience Interest Group.
Author:
Miller, Richard. National Institutes of Health (U.S.). Geroscience Interest Group.
Publisher:
[Bethesda, Md. : National Institutes of Health, 2012]
Abstract:
(CIT): The Geroscience Interest Group (GSIG) cordially invites you to the seminar presented by Dr. Richard Miller. Dr. Miller is a Professor of Pathology and Director of the Nathan Shock Center on Aging at the University of Michigan. He directs one of the three laboratories involved in the NIA-sponsored Interventions Testing Program (ITP) and in that capacity made a seminal contribution to the discovery that rapamycin increases lifespan in mice. His seminar will provide further research information on the ITP, rapamycin and other anti-aging interventions. He has a wide interest in biogerontology, with a special emphasis on the use of animal models to study mechanisms regulating longevity and stress resistance.
Subjects:
Aging Chronic Disease--prevention & control Drug Therapy Longevity
